|
CIRH1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.770400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.830400E-01 |
| Normal-vs-Stage2 |
3.803200E-01 |
| Normal-vs-Stage3 |
8.210500E-02 |
| Normal-vs-Stage4 |
3.483900E-02 |
| Stage1-vs-Stage2 |
6.334200E-02 |
| Stage1-vs-Stage3 |
6.999100E-04 |
| Stage1-vs-Stage4 |
3.597200E-04 |
| Stage2-vs-Stage3 |
5.339400E-01 |
| Stage2-vs-Stage4 |
2.834800E-01 |
| Stage3-vs-Stage4 |
5.464600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.448800E-01 |
| Normal-vs-AfricanAmerican |
7.858000E-01 |
| Normal-vs-Asian |
8.943000E-01 |
| Caucasian-vs-AfricanAmerican |
9.503000E-01 |
| Caucasian-vs-Asian |
9.434000E-01 |
| AfricanAmerican-vs-Asian |
9.821200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.206220E-01 |
| Normal-vs-Female |
2.813600E-01 |
| Male-vs-Female |
9.70299999999424E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.842000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.492400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.562800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.198600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.598200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.544800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.771200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.074000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.711600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.060400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.812600E-01 |
| Normal-vs-Grade 2 |
8.168800E-01 |
| Normal-vs-Grade 3 |
8.408600E-01 |
| Normal-vs-Grade 4 |
1.703870E-03 |
| Grade 1-vs-Grade 2 |
2.980000E-01 |
| Grade 1-vs-Grade 3 |
2.471800E-01 |
| Grade 1-vs-Grade 4 |
4.126100E-02 |
| Grade 2-vs-Grade 3 |
5.400800E-01 |
| Grade 2-vs-Grade 4 |
4.97580000002884E-06 |
| Grade 3-vs-Grade 4 |
2.023500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.597400E-03 |
| Normal-vs-ccB subtype |
2.478300E-03 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.504400E-01 |
| Normal-vs-N1 |
8.193600E-02 |
| N0-vs-N1 |
7.442400E-02 |
|
|
